Market Rally Persists; Nike Plummets to 11-Year Low, Eli Lilly Surges on GLP-1 Approval, Microsoft and Chevron Eye $7B Energy Venture
U.S. markets continued their upward trajectory, extending Tuesday's rally as the Nasdaq Composite closed up over 1% and the Dow Jones Industrial Average gained approximately 0.5%. Investors are now looking ahead to the upcoming jobless claims data, which is anticipated to provide further insights into the labor market.
Despite the broader market's positive momentum, athletic giant Nike experienced a significant downturn, with its shares plummeting over 15% to an 11-year low. This decline occurred despite the company reporting an earnings beat, as investor sentiment was reportedly dampened by dissatisfaction with its turnaround strategies and ongoing concerns regarding its performance in the crucial China market. In stark contrast, pharmaceutical giant Eli Lilly saw its stock rally by more than 3.5% following the U.S. Food and Drug Administration's (FDA) approval for its new GLP-1 competitor pill, signaling strong market confidence in its latest therapeutic offering.
Adding to the day's corporate headlines, technology behemoth Microsoft and energy major Chevron are reportedly engaged in exclusive discussions to develop a substantial $7 billion energy center in West Texas. This ambitious project is initially projected to generate 2500 megawatts of electricity, highlighting a potential significant collaboration between the tech and energy sectors.
Get Weekly Market Signals
Join the mailing list for top aggregated insights. No spam, ever.